Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
43,318
Sort by:
2015 Strategies in the European Nucleic Acid Testing Market
US$ 15,760.00
... years. The report explores business and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test ... managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most ...
May 2015
1273 pages
2015 Strategies in the French Coagulation Testing Market
US$ 4,880.00
... market entrants identify and evaluate business opportunities emerging in the French coagulation testing market during the next five years. The report explores business and technological trends in the French coagulation testing market; provides estimates of the test volume, as well ...
May 2015
405 pages
2015 Strategies in the French Flow Cytometry Market
US$ 3,120.00
... presents a comprehensive analysis of the French flow cytometry market, including: Major issues pertaining to the French flow cytometry practice, as well ... know-how, new products in R&D, collaborative arrangements, and corporate strategies. Business opportunities and strategic recommendations for suppliers. ...
May 2015
146 pages
2015 Strategies in the French Hemostasis Diagnostic Testing Market
US$ 4,880.00
... market entrants identify and evaluate business opportunities emerging in the French coagulation testing market during the next five years. The report explores business and technological trends in the French coagulation testing market; provides estimates of the test volume, as well ...
May 2015
405 pages
2015 Strategies in the French Nucleic Acid Testing Market
US$ 5,360.00
... 125-page market segmentation analysis of the French NAT market. Major issues pertaining to the French NAT laboratory practice, as well as key ... , new products in R&D, collaborative arrangements and business strategies. Alternative market penetration strategies. Potential market entry barriers and risks. Business ...
May 2015
1125 pages
2015 Strategies in the German Coagulation Testing Market
US$ 4,880.00
... market entrants identify and evaluate business opportunities emerging in the German coagulation testing market during the next five years. The report explores business and technological trends in the German coagulation testing market; provides estimates of the test volume, as well ...
May 2015
406 pages
2015 Strategies in the German Flow Cytometry Market
US$ 3,120.00
... presents a comprehensive analysis of the German flow cytometry market, including: Major issues pertaining to the German flow cytometry practice, as well ... know-how, new products in R&D, collaborative arrangements, and corporate strategies. Business opportunities and strategic recommendations for suppliers. ...
May 2015
147 pages
2015 Strategies in the German Hemostasis Diagnostic Testing Market
US$ 4,880.00
... market entrants identify and evaluate business opportunities emerging in the German coagulation testing market during the next five years. The report explores business and technological trends in the German coagulation testing market; provides estimates of the test volume, as well ...
May 2015
406 pages
2015 Strategies in the German Nucleic Acid Testing Market
US$ 5,360.00
... 125-page market segmentation analysis of the German NAT market. Major issues pertaining to the German NAT laboratory practice, as well as key ... , new products in R&D, collaborative arrangements and business strategies. Alternative market penetration strategies. Potential market entry barriers and risks. Business ...
May 2015
1125 pages
2015 Strategies in the Global Coagulation Testing Market
US$ 27,600.00
Complete report $34,500. DataPack (test volumes, sales forecasts, supplier shares) $21,100. Summary This comprehensive seven-country report contains 650 pages, 150 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the ...
May 2015
650 pages
2015 Strategies in the Global Flow Cytometry Market
US$ 14,800.00
Complete report $18,500. DataPack (test volumes, sales forecasts, supplier shares) $7,400. This 7-country report will help current suppliers and potential market entrants identify and evaluate emerging opportunities in the flow cytometry markets during the next five years. The report explores future ...
May 2015
358 pages
2015 Strategies in the Global Hemostasis Diagnostic Testing Market
US$ 27,600.00
Complete report $34,500. DataPack (test volumes, sales forecasts, supplier shares) $21,100. This comprehensive seven-country report contains 650 pages, 150 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the global ...
May 2015
650 pages
2015 Strategies in the Global Nucleic Acid Testing Market
US$ 27,600.00
... , managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging ... years. Design criteria for new products. Alternative market penetration strategies. Potential market entry barriers and risks. Business planning issues ...
May 2015
1398 pages
2015 Strategies in the Italian Coagulation Testing Market
US$ 4,880.00
... market entrants identify and evaluate business opportunities emerging in the Italian coagulation testing market during the next five years. The report explores business and technological trends in the Italian coagulation testing market; provides estimates of the test volume, as well ...
May 2015
402 pages
2015 Strategies in the Italian Flow Cytometry Market
US$ 3,120.00
... presents a comprehensive analysis of the Italian flow cytometry market, including: Major issues pertaining to the Italian flow cytometry practice, as well ... know-how, new products in R&D, collaborative arrangements, and corporate strategies. Business opportunities and strategic recommendations for suppliers. ...
May 2015
142 pages
2015 Strategies in the Italian Hemostasis Diagnostic Testing Market
US$ 4,880.00
... market entrants identify and evaluate business opportunities emerging in the Italian coagulation testing market during the next five years. The report explores business and technological trends in the Italian coagulation testing market; provides estimates of the test volume, as well ...
May 2015
402 pages
2015 Strategies in the Italian Nucleic Acid Testing Market
US$ 5,360.00
... -page market segmentation analysis of the Italian NAT market. Major issues pertaining to the Italian NAT laboratory practice, as well as key ... , new products in R&D, collaborative arrangements and business strategies. Alternative market penetration strategies. Potential market entry barriers and risks. Business ...
May 2015
1117 pages
2015 Strategies in the Japanese Coagulation Testing Market
US$ 5,920.00
... market entrants identify and evaluate business opportunities emerging in the Japanese coagulation testing market during the next five years. The report explores business and technological trends in the Japanese coagulation testing market; provides estimates of the test volume, as well ...
May 2015
402 pages
2015 Strategies in the Japanese Flow Cytometry Market
US$ 3,920.00
... a comprehensive analysis of the Japanese flow cytometry market, including: Major issues pertaining to the Japanese flow cytometry practice, as well ... know-how, new products in R&D, collaborative arrangements, and corporate strategies. Business opportunities and strategic recommendations for suppliers. ...
May 2015
142 pages
2015 Strategies in the Japanese Hemostasis Diagnostic Market
US$ 5,920.00
... market entrants identify and evaluate business opportunities emerging in the Japanese coagulation testing market during the next five years. The report explores business and technological trends in the Japanese coagulation testing market; provides estimates of the test volume, as well ...
May 2015
402 pages
2015 Strategies in the Japanese Nucleic Acid Testing Market
US$ 6,800.00
... -page market segmentation analysis of the Japanese NAT market. Major issues pertaining to the Japanese NAT laboratory practice, as well as key ... new products in R&D, collaborative arrangements and business strategies. Alternative market penetration strategies. Potential market entry barriers and risks. Business ...
May 2015
1126 pages
2015 Strategies in the Spanish Coagulation Testing Market
US$ 4,880.00
... market entrants identify and evaluate business opportunities emerging in the Spanish coagulation testing market during the next five years. The report explores business and technological trends in the Spanish coagulation testing market; provides estimates of the test volume, as well ...
May 2015
400 pages
2015 Strategies in the Spanish Flow Cytometry Market
US$ 3,120.00
... presents a comprehensive analysis of the Spanish flow cytometry market, including: Major issues pertaining to the Spanish flow cytometry practice, as well ... know-how, new products in R&D, collaborative arrangements, and corporate strategies. Business opportunities and strategic recommendations for suppliers. ...
May 2015
140 pages
2015 Strategies in the Spanish Hemostasis Diagnostic Testing Market
US$ 4,880.00
... market entrants identify and evaluate business opportunities emerging in the Spanish coagulation testing market during the next five years. The report explores business and technological trends in the Spanish coagulation testing market; provides estimates of the test volume, as well ...
May 2015
400 pages
2015 Strategies in the Spanish Nucleic Acid Testing Market
US$ 5,360.00
... -page market segmentation analysis of the Spanish NAT market. Major issues pertaining to the Spanish NAT laboratory practice, as well as key ... , new products in R&D, collaborative arrangements and business strategies. Alternative market penetration strategies. Potential market entry barriers and risks. Business ...
May 2015
1117 pages
2015 Strategies in the UK Coagulation Testing Market
US$ 4,880.00
Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. Summary This comprehensive report contains 409 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation ...
May 2015
409 pages
2015 Strategies in the UK Flow Cytometry Market
US$ 3,120.00
... , technological know-how, new products in R&D, collaborative arrangements, and corporate strategies. Business opportunities and strategic recommendations for suppliers. Contains 146 ...
May 2015
146 pages
2015 Strategies in the UK Hemostasis Diagnostic Testing Market
US$ 4,880.00
Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. Summary This comprehensive report contains 409 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation ...
May 2015
409 pages
2015 Strategies in the UK Nucleic Acid Testing Market
US$ 5,360.00
... -how, new products in R&D, collaborative arrangements and business strategies. Alternative market penetration strategies. Potential market entry barriers and risks. Business planning ...
May 2015
1122 pages
2015 Strategies in the US Coagulation Testing Market
US$ 7,680.00
Complete report $9,600. DataPack (test volumes, sales forecasts, supplier shares) $6,200. Summary This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation ...
May 2015
424 pages
2015 Strategies in the US Flow Cytometry Market
US$ 5,360.00
... , technological know-how, new products in R&D, collaborative arrangements, and corporate strategies. Business opportunities and strategic recommendations for suppliers. Contains 174 ...
May 2015
174 pages
2015 Strategies in the US Hemostasis Diagnostic Testing Market
US$ 7,680.00
Complete report $9,600. DataPack (test volumes, sales forecasts, supplier shares) $6,200. Summary This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation ...
May 2015
424 pages
2015 Strategies in the US Nucleic Acid Testing Market
US$ 7,600.00
... -how, new products in R&D, collaborative arrangements and business strategies. Alternative market penetration strategies. Potential market entry barriers and risks. Business planning ...
May 2015
1157 pages
Global Prostate Cancer Therapeutics Market to 2020
US$ 1,000.00
... position, while immunotherapy for prostate cancer stands at the last positon in the prostate cancer therapeutics market. Prostate Cancer Drugs Analysis: Zytiga leads the prostate cancer drugs market in 2014. Zytiga is facing ... “Global Prostate Cancer Therapeutics Market to 2020” is a 76 page report with 43 Figures and 4 Tables. This report analyses the Prostate Cancer Therapy Market, Prostate Cancer Drugs Market, driving factors and challenges for prostate cancer market ...
May 2015
76 pages
Global Melanoma Therapeutics Industry 2015 Market Research Report
US$ 2,850.00
2015 Global Melanoma Therapeutics Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Melanoma Therapeutics industry, focusing on the main ... with: 1.) basic information; 2.) the Asia Melanoma Therapeutics industry; 3.) the North American Melanoma Therapeutics industry; 4.) the European Melanoma Therapeutics industry; 5.) market entry and investment feasibility ...
May 2015
170 pages
Global Breast Cancer Monoclonal Antibodies Market Outlook 2020
US$ 1,800.00
... Cancer Monoclonal Antibodies Pipeline: 62 mAb Majority Breast Cancer Monoclonal Antibodies in Preclinical Phase: 17 mAb Marketed Breast Cancer Monoclonal Antibodies: 6 mAb Marketed Breast Cancer Monoclonal Antibodies Clinical Insight Bevacizumab (Avastin) Pertuzumab (Omnitarg, Perjeta) Trastuzumab (Herceptin ...
May 2015
190 pages
US Non-Invasive Prenatal Testing Market Outlook 2020
US$ 1,200.00
... industry with market is driven by companies developing and offering these tests. The average age of women giving birth in United States has ... for NIPT tests which have emerged as the next big thing in the field of prenatal diagnostics. According to our report, “US Non-Invasive Prenatal Testing Market Outlook ...
April 2015
70 pages
Global Point-of-Care Diagnostics Market Outlook 2020
US$ 1,000.00
... of care and ever-increasing integration of technology into healthcare, the global POCT market is expected to grow to almost US$ 30 Billion by 2020. According to “Global Point-of-Care Diagnostics Market Outlook 2020”, the global POCT ... supported the growth of Point of Care testing. At the same time, rapid advancements in technology and infrastructure and the availability of diagnostic systems that cannot ...
April 2015
75 pages
Personalised Medicines in Oncology: Assessing Key Drivers and Challenges at the Physician Level (US)
US$ 6,900.00
... value and benefits of personalised medicine and on the key challenges and opportunities in relation to implementation from treating oncologists. Personalised Medicines in Oncology: Assessing Key Drivers and Challenges ... to development, access and implementation of personalised healthcare strategies. This survey provides US physician insights into personalised medicine within the oncology setting. By understanding what oncologists ...
April 2015
The Future of Cancer Immunotherapy: KOL Views Bring Opportunities into Sharp Focus
US$ 1,950.00
... the best results. The bottom line here is that cancer immunotherapies will revolutionise cancer treatment and the fortunes of the companies who bring ... -Sarcoma Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA Paolo A. Ascierto, MD, Cancer Immunotherapy and Innovative Therapy Unit Istituto Nazionale ...
April 2015
Physician Views: Five key diabetes market questions ahead of ADA 2014
US$ 695.00
... product to Lantus now known as Toujeo. See Physician Views Poll Results – Usage of Sanofi's U300 will not ... this point. In the oral diabetes market, there are two key trends to watch. In the GLP ... , FirstWord is polling US and EU5-based endocrinologists on five key questions ahead of the ADA meeting, Specifically ...
April 2015
